May 08, 2013 (Fast Lane via COMTEX) -- Analysis was conducted on the Pharmaceuticals industry to measure relative performance to find stocks that have underperformed. Relative underperformance is a possible bearish sign of underlying fundamental and technical weakness should it continue for an extended period of time. We looked at yesterday's price action of all companies in this peer group and measured their performance against one another. Akorn (NASDAQ:AKRX) ranks first with a loss of 7.46%; Impax Laboratories (NASDAQ:IPXL) ranks second with a loss of 3.48%; and Questcor Pharmaceuticals (NASDAQ:QCOR) ranks third with a loss of 2.59%.
Perrigo (NASDAQ:PRGO) follows with a loss of 2.15% and Vivus (NASDAQ:VVUS) rounds out the bottom five with a loss of 1.63%.Akorn, Inc. develops, manufactures, and markets ophthalmic and injectable pharmaceutical products. The Company sells various diagnostic and therapeutic pharmaceutical products focused primarily on ophthalmology, anesthesia, antidotes, and rheumatology. Akorn also markets ophthalmic surgical instruments and other supplies, and provides contract manufacturing for third parties.
---------------------------------------------------------------------------------------------
Financial News Network Online (FNNO) is a leading provider of digital financial news content for distribution on the web. You can count on FNNO to bring you the latest market news, earnings reports, analyst comments, economic data reports and more. Visit http://www.fnno.com today.
Copyright, Comtex News Network, Inc. 2013
